“Semi-Supervised Learning Algorithm for Identifying High Priority Drug-Drug Interactions through Adverse Event Reports”
Date: Tuesday, November 5
Time: 10:30 a.m.–12:00 p.m.
Location: 233A HUB-Robeson Center and Streamed Live on Zoom
Presenter: Soundar Kumara, Allen E. Pearce and Allen M. Pearce Professor of Industrial Engineering
Abstract: We will discuss few of the major studies conducted by LISA (Laboratory of Intelligent Systems and Analytics) in healthcare using AI and Machine Learning. We will detail the drug-to-drug interactions (DDIs) work. Identifying drug-drug interactions (DDIs) is a critical enabler for reducing adverse drug events and improving patient safety. Generating proper DDI alerts during patient prescription workﬂow has the potential to prevent DDI-related adverse events, and such an alerting system has received much attention worldwide. However, to improve the contents of DDI alerts without causing alert fatigue still remains a challenge. One strategy is to establish a list of high-priority DDIs for alerting purposes though it is a resource-intensive task. In this study, we propose a machine learning framework to extract useful features from the FDA adverse event reports, and then identify potential high-priority DDIs using an autoencoder-based semi-supervised learning algorithm. The experimental results demonstrate the effectiveness of using adverse event feature representations in differentiating high- and low-priority DDIs. Additionally, the proposed algorithm utilizes stacked autoencoders and weighted support vector machine to boost classiﬁcation performance, which outperforms other competing methods in terms of F-measure and AUC score. This framework integrates multiple information sources, leverages domain knowledge and clinical evidence, and provides a practical approach to pre-screen high-priority DDI candidates for use in DDI alerting systems. The talk will be more application based.